Chronic Kidney Disease (CKD)

CKD is a condition in which the kidneys are damaged or cannot filter blood as well as healthy kidneys, often as a result of fibrosis. Because of this, excess fluid
and waste from the blood remain in the body and may cause other health problems.
The global market for CKD drugs continues to proliferate at a significant pace, driven by the increasing number of CKD patients and the growing need of novel
treatments to improve patients’ quality of life. According to Research and Markets, the global Chronic Kidney Disease (CKD) Drugs market was valued
at US$ 12.4B in 2016, and is expected to reach US$ 17.4B by 2025, expanding at a CAGR of 3.9% from 2017 to 2025.

Market Projection*

(in US$ Billions)

*According to Research and Markets.